Novo Nordisk A/S News Headlines

NVO 
$45.81
*  
0.10
0.22%
Get NVO Alerts
*Delayed - data as of Jul. 28, 2014 12:10 ET  -  Find a broker to begin trading NVO now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    NVO Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Tracking Ken Fisher's Fisher Asset Management Portfolio - Q2 2014 Update
7/28/2014 6:12:00 AM - Seeking Alpha

5 More Possible Partners For MannKind's Afrezza, Each With A Strong Diabetes Care Franchise
7/21/2014 9:53:00 AM - Seeking Alpha

The Global Guru: What are the Top Five Global Stock Markets of 2014?
7/9/2014 10:09:28 AM - Eagle Financial Publications

Sanofi's Basal Insulin Candidate Under FDA Review - Analyst Blog
7/8/2014 6:40:00 PM - Zacks.com

Novo Nordisk Gets FDA Nod for NovoSeven RT - Analyst Blog
7/8/2014 11:30:00 AM - Zacks.com

Zafgen Appoints Patrick Loustau As President - Quick Facts
7/1/2014 8:08:00 AM - RTT News

Pre-Market Most Active for Jun 27, 2014 : AAXJ, AMSG, ERIC, BCS, GPRO, BAC, MTW, DSGX, FB, TWTR, NVO, PUK
6/27/2014 8:39:54 AM - NASDAQ.com News

MannKind's Clock Is Ticking, But Balance Sheet Sounds An Alarm
6/27/2014 2:22:00 AM - Seeking Alpha

Novo Nordisk's Diabetes Pill Shows Promise
6/26/2014 6:05:00 PM - Seeking Alpha

Sanofi: Toujeo Is Not The Ace In Its Deck
6/23/2014 4:32:00 PM - Seeking Alpha

Novo Nordisk Reveals Positive Data on Victoza 3 mg - Analyst Blog
6/23/2014 11:30:00 AM - Zacks.com

The Anti-Obesity Space Is Not As Simple As Some Think
6/20/2014 11:34:00 AM - Seeking Alpha

Novo Nordisk (NVO) is in Overbought Territory: What's Next? - Tale of the Tape
6/18/2014 9:46:12 AM - Zacks.com

Ligand Pharma's LGD-6972 Positive in Phase I Study - Analyst Blog
6/17/2014 4:35:00 PM - Zacks.com

Novo Nordisk's Victoza 3 mg Positive in Phase III - Analyst Blog
6/16/2014 4:45:00 PM - Zacks.com

Sanofi's Diabetes Portfolio in Focus at American Diabetes Association Sessions - Analyst Blog
6/16/2014 4:30:00 PM - Zacks.com

Eli Lilly Impresses at American Diabetes Association Sessions - Analyst Blog
6/16/2014 11:10:00 AM - Zacks.com

Novo Nordisk Raises Insulin Prices As Demand Grows
6/13/2014 5:29:00 PM - Investor's Business Daily

Vivus Suit Preserves Exclusivity Of Qsymia - For Now
6/13/2014 2:56:00 PM - Seeking Alpha

Pre-Market Most Active for Jun 13, 2014 : INTC, ACAS, FNSR, YELP, OPEN, NVO, GRPN, EXPR, AAPL, PHG, ALU, TWTR
6/13/2014 8:39:54 AM - NASDAQ.com News

Pre-Market Most Active for Jun 11, 2014 : ING, MTU, BAC, ACHN, OREX, MU, LYG, FB, OSUR, AAPL, NVO, TWTR
6/11/2014 8:39:53 AM - NASDAQ.com News

MannKind Hits 52-Week High - Analyst Blog
6/6/2014 8:00:00 AM - Zacks.com

The Importance Of Being Oral
6/3/2014 6:32:00 PM - Seeking Alpha

FDA Panel to Review Novo Nordisk's Victoza 3mg - Analyst Blog
5/21/2014 5:35:00 PM - Zacks.com

Investors Should Cheer Novo Nordisk Study Results
5/19/2014 4:39:00 PM - Seeking Alpha